YOUR FORESIGHT. HIS FUTURE.
The first NOAC with
a reversal agent

YOUR FORESIGHT.
HIS FUTURE.

 
 
 

AF Guidelines , Appropriate NOAC dosing based on Co morbidities and Clinical Practice - Prof. Jan Steffel (Tiếng Việt)

Document ID: PC-VN-101398

06/04/2022

Author: Boehringer Ingelheim

Related content

 
PC-VN-101398
Production date: April 2022